top of page

Welcome to BioStruct-Africa Kenya

Centre for AI-Enabled Structural Biology for Drug and Vaccine Discovery (CASBio-DVD)

Diagram Arrow Alignment Fix (2)_edited_e

Structure-Guided
Drug Discovery Paradigm   

Structure-Guided
Vaccine Discovery Paradigm  

Research Focus

Our research addresses three major health challenges affecting Africa: malaria, schistosomiasis, and drug-resistant bacterial infections.

​

By integrating AI-enabled structural biology with experimental approaches, we investigate the molecular mechanisms underlying these conditions with a focus on nutrient uptake in malaria and schistosomiasis parasites and mechanisms of acid resistance in drug-resistant bacteria, with the goal of identifying small-molecule and nanobody therapeutics.

​

We also pursue structure-guided vaccine design targeting Schistosoma mansoni calpain.

BSA_MALARIA3.png

MALARIA

​

Cadaverine Acid Resistance Pathway.png

ANTIMICROBIAL RESISTANCE

BSA_Schistosomiasis2.png

SCHISTOSOMIASIS

​

Research Expertise & Tools

 

We combine computational prediction with laboratory validation to take proteins from sequence to structure to function.​


01

AI & Computational Methods

Protein Structure Prediction and Analysis

Predict 3D models from sequence to guide target selection and experiments.

​

Molecular Modelling and Interactions

Model how proteins bind ligands and partners to prioritise candidates.​

Molecular Dynamics Simulations

Simulate how proteins move, bind and change shape over time.

​

Normal Mode Analysis (NMA)

Reveal large-scale flexibility and motions that relate to function.

​

02

Experimental Methods

Protein Expression and Purification

Produce pure, well-behaved protein for structural and functional work.

Stability Measurements (GFP-TS)

GFP-based thermal-shift screening to find stable constructs and conditions.

X-ray Crystallography

Atomic-resolution structures of purified target proteins.

Cryo-Electron Microscopy

Structures of membrane and soluble proteins in complex with ligand, nanobodies and antibodies.

Nanobodies Discovery (AfriBodies)

Discover nanobodies against your target for research and therapeutic leads.

Functional Assay Development

Custom assays that confirm a structure works as predicted.

Structures & Discoveries 

 

Explore some experimentally determined protein structures from research involving BioStruct-Africa Kenya scientists and collaborators.


6rw3_assembly-1.jpeg
6RW3

PfHT1 transporter

Structural insights into the gating dynamics that regulate sugar import in Plasmodium falciparum.

​

View deposited stucture

9eyd_assembly-1.jpeg
9EYD 

LysP Transporter​

How Pseudomonas aeruginosa recognises and transports lysine, a process linked to bacterial acid resistance.​

​

View deposited structure

​

6i1r_assembly-1.jpeg
6I1R

CMP-sialic acid transporter​

Understanding the structural basis of activated sialic acid into golgi for sialyation.​

 

View deposited structure

Selected Publications

Nji, E. AlphaFold can help African researchers to do cutting-edge structural biology. Nature 649, 555 (2026).
 

Bicer, D., Matsuoka, R., Moumbock, A. F. A., Sukumar, P., Suades, A., Cheruvara, H., Quigley, A., Drew, D., Pardon, E., Steyaert, J., Henderson, P. J. F., Caffrey, M., Griese, J. J. & Nji, E. Structural basis of specific lysine transport by Pseudomonas aeruginosa permease LysP. Nat. Commun. 17, 37 (2025).


Nji, E., Cramer, K. C., Rüffin, N. V., Fofana, F. G., Heiba, W. & Sankhe, S. Leveraging AlphaFold for innovation and sustainable health research in Africa. Nat. Commun. 16, 1334 (2025).

​

Amofa, J. O. et al. BioStruct-Africa’s scalable framework for AlphaFold-enabled research training and sustainable workforce development in Africa. Commun. Biol. 9, 321 (2026).

​

Sankhe, S. et al. BioStruct-Africa’s capacity-building workshops as a model for advancing the emerging community of structural biologists in Africa. Commun. Chem. 8, 118 (2025).

​

Nji, E., Moumbock, A. F. A., Cramer, K. C., Rüffin, N. V., Davis, J., Asojo, O. A., Griese, J. J., Larbi, A. A. & Fodje, M. N. Supporting structural biologists in Africa requires resources and capacity building. Nat. Struct. Mol. Biol. 31, 1814–1815 (2024).


Martinez-Molledo, M., Nji, E. & Reyes, N. Structural insights into lysophospholipid brain uptake mechanism and its inhibition by human cell-fusogen syncytin 2. Nat. Struct. Mol. Biol. 29, 604–612 (2022).


Chatzikyriakidou, Y., Ahn, D.-H., Nji, E. & Drew, D. The GFP thermal shift assay for screening ligand and lipid interactions to solute carrier transporters. Nat. Protoc. 16, 5357–5376 (2021).

​

Thulasingam, M., Orellana, L., Nji, E., Ahmad, S., Rinaldo-Matthis, A. & Haeggström, J. Z. Crystal structures of human MGST2 reveal synchronized conformational changes regulating catalysis. Nat. Commun. 12, 1728 (2021).


Qureshi, A. A., Suades, A., Matsuoka, R., Brock, J., McComas, S. E., Nji, E., Orellana, L., Claesson, M., Delemotte, L. & Drew, D. The molecular basis for sugar import in malaria parasites. Nature 578, 321–325 (2020).


Nji, E., Gulati, A., Qureshi, A. A., Coincon, M. & Drew, D. Structural basis for the delivery of activated sialic acid into the Golgi for sialylation. Nat. Struct. Mol. Biol. 26, 415–423 (2019).


Nji, E., Chatzikyriakidou, Y., Landreh, M. & Drew, D. An engineered thermal-shift screen reveals specific lipid preferences of eukaryotic and prokaryotic membrane proteins. Nat. Commun. 9, 4253 (2018).


Uzdavinys, P., Coinçon, M., Nji, E., Ndi, M., Winkelmann, I., von Ballmoos, C. & Drew, D. Dissecting the proton transport pathway in electrogenic Na+/H+ antiporters. Proc. Natl Acad. Sci. USA 114, E1101–E1110 (2017).

Our Team

IMG_7639 3.jpg
Dr Emmanuel Nji

Principal Investigator 

CEO & Founder 

  • LinkedIn
ALIA_2.jpeg
C. Alia Joko

Research Communications Lead 

  • LinkedIn
justice.jpg
Justice Amofa

Doctoral Researcher

  • LinkedIn
Juergen_image_edited_edited.jpg
Juergen George

Doctoral Researcher

  • LinkedIn
IreneMuiruri.jpg
Irene Muiruri

Doctoral Researcher

  • LinkedIn

Contact

bottom of page